Gene · 3738
Papers2,009
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,009
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Use of tetraethylammonium (TEA) and Tris loading for blocking TRPM7 channels in intact cells. | Front Pharmacol | 2024 | 38659572 | PubTator, text mining | PubMed |
| Effect of the rs2821557 Polymorphism of the Human Kv1.3 Gene on Olfactory Function and BMI in Different Age Groups. | Nutrients | 2024 | 38542732 | PubTator, text mining | PubMed |
| Report from the 29th Meeting on Toxinology, "Toxins: From the Wild to the Lab", Organized by the French Society of Toxinology on 30 November-1 December 2023. | Toxins (Basel) | 2024 | 38535813 | PubTator, text mining | PubMed |
| KcsA-Kv1.x chimeras with complete ligand-binding sites provide improved predictivity for screening selective Kv1.x blockers. | J Biol Chem | 2024 | 38479597 | PubTator, text mining | PubMed |
| Structural modeling of ion channels using AlphaFold2, RoseTTAFold2, and ESMFold. | Channels (Austin) | 2024 | 38445990 | PubTator, text mining | PubMed |
| Activity of Potassium Channels in CD8+ T Lymphocytes: Diagnostic and Prognostic Biomarker in Ovarian Cancer? | Int J Mol Sci | 2024 | 38396628 | PubTator, text mining | PubMed |
| Recent Advances in Real-Time Label-Free Detection of Small Molecules. | Biosensors (Basel) | 2024 | 38391999 | PubTator, text mining | PubMed |
| Kv1.3 in the spotlight for treating immune diseases. | Expert Opin Ther Targets | 2024 | 38316438 | PubTator, text mining | PubMed |
| Revealing Propolis Potential Activity on Inhibiting Estrogen Receptor and Heat Shock Protein 90 Overexpressed in Breast Cancer by Bioinformatics Approaches. | Bioinform Biol Insights | 2024 | 38274992 | PubTator, text mining | PubMed |
| Exploring the potential of Brazilian Amazonian scorpion venoms: A comprehensive review of research from 2001 to 2021. | Toxicon X | 2024 | 38226138 | PubTator, text mining | PubMed |
| Genomic insights and prognostic significance of novel biomarkers in pancreatic ductal adenocarcinoma: A comprehensive analysis. | Biochem Biophys Rep | 2024 | 38107664 | PubTator, text mining | PubMed |
| Methotrexate and electrostimulation cooperate to alleviate the relapse of psoriasiform skin inflammation by suppressing memory T cells. | Biochem Pharmacol | 2024 | 38081367 | PubTator, text mining | PubMed |
| Glucocorticoids modulate neural activity via a rapid non-genomic effect on Kv2.2 channels in the central nervous system. | Neurobiol Stress | 2024 | 38075025 | PubTator, text mining | PubMed |
| Intracellular K+ Limits T-cell Exhaustion and Preserves Antitumor Function. | Cancer Immunol Res | 2024 | 38063845 | PubTator, text mining | PubMed |
| De novo variants in KCNA3 cause developmental and epileptic encephalopathy. | Ann Neurol | 2024 | 37964487 | PubTator, text mining | PubMed |
| Exome-wide comparative analyses revealed differentiating genomic regions for performance traits in Indian native buffaloes. | Anim Biotechnol | 2024 | 37934017 | PubTator, text mining | PubMed |
| Genome-wide methylation profiling identified methylated KCNA3 and OTOP2 as promising diagnostic markers for esophageal squamous cell carcinoma. | Chin Med J (Engl) | 2024 | 37650127 | PubTator, text mining | PubMed |
| Dynamics and spatial organization of Kv1.3 at the immunological synapse of human CD4+ T cells. | Biophys J | 2024 | 37596785 | PubTator, text mining | PubMed |
| Kv1.3 blockade by ShK186 modulates CD4+ effector memory T-cell activity of patients with granulomatosis with polyangiitis. | Rheumatology (Oxford) | 2024 | 37086441 | PubTator, text mining | PubMed |
| Reduction of inflammation and mitochondrial degeneration in mutant SOD1 mice through inhibition of voltage-gated potassium channel Kv1.3. | Front Mol Neurosci | 2023 | 38292023 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3738/papers?page=7